β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (663) π οΈ Industry Q&A (164) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ SEC Filings
| Date accepted | Link | Final link |
|---|---|---|
| 2026-06-08 16:29:04 | 4 | 4 final |
| 2026-06-08 16:28:03 | 4 | 4 final |
| 2026-06-08 16:27:04 | 4 | 4 final |
| 2026-06-08 16:26:14 | 4 | 4 final |
| 2026-06-08 16:24:20 | 4 | 4 final |
| 2026-06-08 16:22:37 | ***** | ***** |
| 2026-06-08 16:21:26 | ***** | ***** |
| 2026-06-08 16:20:18 | ***** | ***** |
| 2026-06-04 16:15:59 | ***** | ***** |
| 2026-05-28 16:48:21 | ***** | ***** |
| 2026-05-28 16:01:40 | ***** | ***** |
| 2026-05-21 21:20:12 | ***** | ***** |
| 2026-05-15 16:38:40 | ***** | ***** |
| 2026-05-15 16:37:04 | ***** | ***** |
| 2026-05-14 14:29:42 | ***** | ***** |
π Explore more SEC filings for Royalty Pharma!
Sign up for free or log inπ Join now to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" at no cost